Ted Karkus - Sep 9, 2025 Form 4 Insider Report for ProPhase Labs, Inc. (PRPH)

Role
CEO & CHAIRMAN, Director
Signature
/s/ Ted Karkus
Stock symbol
PRPH
Transactions as of
Sep 9, 2025
Transactions value $
$0
Form type
4
Date filed
9/11/2025, 04:05 PM
Previous filing
Mar 21, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Karkus Ted William CEO & CHAIRMAN, Director 626 RXR PLAZA, 6TH FLOOR, UNIONDALE, /s/ Ted Karkus 2025-09-09 0001457896

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRPH warrants Award $0 +500K $0.00 500K Sep 9, 2025 Common Stock 500K $0.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Warrants issued upon increase in authorized shares being approved by shareholders. The Reporting Person loaned PRPH funds, with a contingency that a warrant to purchase 500,000 shares of the Issuer's common stock at an exercise price of $0.60 per share would be issued if and only if the company's shareholders approved an amendment to the Certificate of Incorporation increasing the authorized shares of common stock from 50,000,000 to 1,000,000,000. Shareholders approved the increase in the authorized shares on September 9, 2025. The Warrant is described in the Issuer's Current Report on Form 8-K/A filed June 26, 2025 (Item 1.01), which states the Warrant has a five-year term. The expiration date shown (09/09/2030) is a five-year term from the issuance date. The Warrant was issued as consideration in connection with a related-party loan agreement between the Issuer and the Reporting Person dated June 22, 2025. See Form 8-K/A filed June 26, 2025 for additional details.